These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10371185)

  • 1. HIV-negative infants born to HIV-1 but not HIV-2-positive mothers fail to develop a Bacillus Calmette-Guérin scar.
    Ota MO; O'Donovan D; Marchant A; Yamuah L; Harding E; Jaffar S; McAdam KP; Corrah T; Whittle H
    AIDS; 1999 May; 13(8):996-8. PubMed ID: 10371185
    [No Abstract]   [Full Text] [Related]  

  • 2. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants.
    Miles DJ; Gadama L; Gumbi A; Nyalo F; Makanani B; Heyderman RS
    Immunology; 2010 Mar; 129(3):446-54. PubMed ID: 20002789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of Bacillus Calmette-Guerin vaccine in children born to HIV-1 infected women.
    Thaithumyanon P; Thisyakorn U; Punnahitananda S; Praisuwanna P; Ruxrungtham K
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):482-6. PubMed ID: 11289006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers.
    Van Rie A; Madhi SA; Heera JR; Meddows-Taylor S; Wendelboe AM; Anthony F; Violari A; Tiemessen CT
    Clin Vaccine Immunol; 2006 Feb; 13(2):246-52. PubMed ID: 16467333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guérin complications in children born to HIV-1-infected women with a review of the literature.
    O'Brien KL; Ruff AJ; Louis MA; Desormeaux J; Joseph DJ; McBrien M; Coberly J; Boulos R; Halsey NA
    Pediatrics; 1995 Mar; 95(3):414-8. PubMed ID: 7862483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waning immunity to varicella in infants of human immunodeficiency virus-seropositive and -seronegative mothers.
    Choudhury SA; Ladson G; Hills ER; Hatcher F
    Pediatr Infect Dis J; 2011 Sep; 30(9):799-801. PubMed ID: 21412180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
    Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
    Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothers.
    Lallemant-Le Coeur S; Lallemant M; Cheynier D; Nzingoula S; Drucker J; Larouze B
    AIDS; 1991 Feb; 5(2):195-9. PubMed ID: 2031692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concerns on Bacille Calmette-Guerin vaccination in infants born to mothers with hepatitis B virus infection.
    Hu Y; Zhou YH
    Vaccine; 2009 Mar; 27(14):1987-8. PubMed ID: 19428825
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.
    Mansoor N; Scriba TJ; de Kock M; Tameris M; Abel B; Keyser A; Little F; Soares A; Gelderbloem S; Mlenjeni S; Denation L; Hawkridge A; Boom WH; Kaplan G; Hussey GD; Hanekom WA
    J Infect Dis; 2009 Apr; 199(7):982-90. PubMed ID: 19236280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel vaccine prime and selective BCG boost: a new tuberculosis vaccine strategy for infants of HIV-infected mothers.
    Hatherill M; Mahomed H; Hanekom W
    Vaccine; 2010 Jun; 28(29):4550-2. PubMed ID: 20470797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virologic, immunologic, and clinical evaluation of human immunodeficiency virus antibody status of symptom-free children born to infected mothers.
    Wiznia AA; Lambert G; Dobrosyzcki J; Porricolo M; Chelyapov N; Israeli V; Brunell P; Conroy J; Liu KN; Baron P
    J Pediatr; 1994 Sep; 125(3):352-5. PubMed ID: 7915304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacille Calmette-Guerin disease following Bacille Calmette-Guerin vaccination of an HIV-infected health-care worker.
    Vera JH; Hill SC; Rubinstein L
    Int J STD AIDS; 2012 Jul; 23(7):e1-2. PubMed ID: 22844017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of bacille Calmette-Guerin vaccination in HIV-positive infants.
    Hussey G; Hawkridge T; Eley B; Nuttall J; Kibel M; Geiter L; Barker L; Behr M; Demers AM
    Clin Infect Dis; 2004 May; 38(9):1333-4; author reply 1334-5. PubMed ID: 15127353
    [No Abstract]   [Full Text] [Related]  

  • 15. Evolution of the Bacillus Calmette-Guerin Scar and Its Association with Birth and Pregnancy Characteristics in a Prospective Cohort of Infants in Iquitos, Peru.
    Schiaffino F; Lee GO; Paredes-Olortegui M; Cabrera L; Penataro-Yori P; Gilman RH; Kosek MN
    Am J Perinatol; 2019 Oct; 36(12):1264-1270. PubMed ID: 30583300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of maternal human immunodeficiency virus status on the outcome of neonates with necrotizing enterocolitis.
    Karpelowsky JS; van Mil S; Numanoglu A; Leva E; Millar AJ
    J Pediatr Surg; 2010 Feb; 45(2):315-8; discussion 318. PubMed ID: 20152343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission.
    Wasik TJ; Bratosiewicz J; Wierzbicki A; Whiteman VE; Rutstein RR; Starr SE; Douglas SD; Kaufman D; Sison AV; Polansky M; Lischner HW; Kozbor D
    J Immunol; 1999 Apr; 162(7):4355-64. PubMed ID: 10201969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral studies of mothers with human immunodeficiency virus infection at delivery and their infants in the first 3 days of life.
    Sison AV; Brandt CD; Rakusan TA; Wientzen R; Fuccillo DA; Sever JL
    Pediatr AIDS HIV Infect; 1996 Oct; 7(5):325-30. PubMed ID: 11361490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
    Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial.
    Gasper MA; Hesseling AC; Mohar I; Myer L; Azenkot T; Passmore JS; Hanekom W; Cotton MF; Crispe IN; Sodora DL; Jaspan HB
    JCI Insight; 2017 Apr; 2(7):e91963. PubMed ID: 28405623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.